Standard Chemical & Pharmaceutical Co. Ltd. (TPE: 1720)

Market Cap	10.88B
Revenue (ttm)	6.71B
Net Income (ttm)	847.58M
Shares Out	178.70M
EPS (ttm)	4.74
PE Ratio	12.85
Forward PE	n/a
Dividend	2.70 (4.43%)
Ex-Dividend Date	Aug 1, 2024

Volume	73,253
Average Volume	180,979
Open	60.90
Previous Close	60.90
Day's Range	60.60 - 61.00
52-Week Range	60.00 - 79.40
Beta	0.13
RSI	39.52
Earnings Date	Feb 27, 2025

About Standard Chemical & Pharmaceutical

Standard Chemical & Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan and internationally. The company offers various pharmaceutical products for metabolic, respiratory, musculoskeletal, digestive, circulatory system, topical dermatological, cardiovascular system, anti-infectives, urogenital system and sex hormones, and others. It engages in processing, manufacturing, and selling of food; and offers western medicine, nourishment, and function food, biochemical nutrition, and ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1967
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1720

Financial Performance

In 2023, Standard Chemical & Pharmaceutical's revenue was 6.24 billion, an increase of 6.64% compared to the previous year's 5.85 billion. Earnings were 834.89 million, an increase of 2.39%.